Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2395-2404
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2395
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2395
Table 3 Estimated 6-, 12-, 18- and 24-mo survival rate
| 6 mo | 12 mo | 18 mo | 24 mo | |
| Treatment group, total (n = 119) | 72.0% | 43.0% | 28.2% | 23.5% |
| Surgical treatment (n = 17) | 88.2% | 76.5% | 64.7% | 64.7% |
| Localized treatment (n = 102) | 69.3% | 37.3% | 22.0% | 16.4% |
| Conservative group (n = 27) | 18.5% | 3.7% | 0% | 0% |
| P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Song DS, Nam SW, Bae SH, Kim JD, Jang JW, Song MJ, Lee SW, Kim HY, Lee YJ, Chun HJ, You YK, Choi JY, Yoon SK. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2015; 21(8): 2395-2404
- URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2395